Desmopressin Acetate
- Product NDC
- 70860-454
- 11-digit product format
- 708600454
- Labeler code
- 70860
- Product ID
- 70860-454_0379ad5e-68ea-4b50-af16-5d96ea97a28a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- desmopressin acetate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA210223
- Marketing category
- ANDA
- Marketing start
- 2020-11-30
- Marketing end
- 0000-00-00
- Substance
- DESMOPRESSIN ACETATE
- Active strength
- 4 ug/mL
- Pharmacologic classes
- Factor VIII Activator [EPC], Increased Coagulation Factor VIII Activity [PE], Increased Coagulation Factor VIII Concentration [PE], Vasopressin Analog [EPC], Vasopressins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-454-01 | 70860045401 | 10 VIAL in 1 CARTON (70860-454-01) > 1 mL in 1 VIAL (70860-454-41) | 10 vial | 2020-11-30 | 0000-00-00 | No | No | Current |
| 70860-454-10 | 70860045410 | 1 VIAL in 1 CARTON (70860-454-10) > 10 mL in 1 VIAL | 1 vial | 2020-11-30 | 0000-00-00 | No | No | Current |